[1]
Hafidh, K., Sakanishi, Y., Hurtado, P., M. V. Ritter, A., Werth, S., Arthaud Berthet Nunes de Souza, A.P., Villarreal Rodriguez, M.F., Valencia Serna, J.A., Gonzalez-Nolasco, B. and de Castro Oliveira, L. 2016. Efficacy and safety of Dapagliflozin vs. Canagliflozin in addition to metformin for treatment of type 2 diabetes, a randomized, double-blind, non-inferiority clinical trial. Principles and Practice of Clinical Research. 2, 1 (Mar. 2016).